Position in NTRA
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$7,018,068
+$2,198,709 QoQ
Shares Held
25,854
+7.3% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#234
of 844 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Chicago Capital, LLC holds $61,266,404 across 6 Diagnostics & Research names. NTRA ranks #3 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
74,297 | $39,112,912 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
20,642 | $10,349,073 | |
| 3 | NTRA |
Natera, Inc.
This page
|
25,854 | $7,018,068 | |
| 4 | DHR |
Danaher Corp /De/
|
18,818 | $3,584,452 | |
| 5 | LH |
Labcorp Holdings Inc.
|
3,000 | $840,000 | |
| 6 | GRAL |
GRAIL, Inc.
|
5,301 | $361,899 |
All Filings in NTRA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,018,068 | 25,854 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $4,819,359 | 24,098 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $3,452,615 | 15,071 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $364,758 | 2,266 | Shares | Sole | 2025-10-22 | |
| No filing history on record for this holder in this stock. | ||||||